Showing results (381-390 of 462) with videos related to

Sort By:
Pageof 47
Health Technology Assessment (Winchester, England)|July 12, 2014
The opportunities and challenges of pragmatic point-of-care randomised trials using routinely collected electronic records: evaluations of two exemplar trialsTjeerd-Pieter van Staa, Lisa Dyson, Gerard McCann, et al.
The Journal of Clinical Investigation|May 16, 2017
Molecular isoforms of high-mobility group box 1 are mechanistic biomarkers for epilepsyLauren Elizabeth Walker, Federica Frigerio, Teresa Ravizza, et al.
Circulation. Cardiovascular Genetics|August 10, 2017
CKM Glu83Gly Is Associated With Blunted Creatine Kinase Variation, but Not With MyalgiaMoneeza Kalhan Siddiqui, Abirami Veluchamy, Cyrielle Maroteau, et al.
NPJ Genomic Medicine|February 16, 2022
A population study of clinically actionable genetic variation affecting drug response from the Middle EastPuthen Veettil Jithesh, Mohammed Abuhaliqa, Najeeb Syed, et al.
Pharmacogenetics and Genomics|September 16, 2009
Genetic and environmental factors determining clinical outcomes and cost of warfarin therapy: a prospective studyAndrea L Jorgensen, Sameh Al-Zubiedi, Jieying Eunice Zhang, et al.
The Journal of Investigative Dermatology|April 2, 2021
HLA Class-II‒Restricted CD8+ T Cells Contribute to the Promiscuous Immune Response in Dapsone-Hypersensitive PatientsQing Zhao, Mubarak Almutairi, Arun Tailor, et al.
Clinical Pharmacology and Therapeutics|May 27, 2020
Genetic Association of Co-Trimoxazole-Induced Severe Cutaneous Adverse Reactions Is Phenotype-Specific: HLA Class I Genotypes and HaplotypesChonlaphat Sukasem, Jirawat Pratoomwun, Patompong Satapornpong, et al.
Pharmacogenomics|October 22, 2009
Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial designRianne M F van Schie, M I A Wadelius, Farhad Kamali, et al.
Pageof 47